Simayijiang Xirenayi

ORCID: 0009-0000-1970-6554

Also affiliated with Quantitative BioSciences, Dana-Farber Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML”.

Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101290

N/A

0.385DataRank · unranked

12 citations

Carlos Stahlhut, Theodore C. Tarver, Sydney Wishner, Bianca J. Lee, Cheryl A.C. Peretz +12 more

Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients

Cancer Reports(2023)10.1002/cnr2.1901

N/A

0DataRank · unranked

5 citations

William C. Temple, Amanda E. Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi +7 more

Evaluation of single-cell RNA profiling technologies using FFPE, fresh, and frozen ccRCC tumor specimens

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.25.690485

N/A

0DataRank · unranked

0 citations

Sabrina Y. Camp, Amanda Garza, Yashika Rustagi, Erica Pimenta, Erin Shannon +9 more